483
Neuland Laboratories Limited (Unit II)Neuland Laboratories Limited (Unit II) – FDA 483, May 2, 2025
Record Details
An FDA inspection of Neuland Laboratories Limited (Unit II) in IDA Pashamylaram Village, India, revealed significant deficiencies in facility design and construction. The firm failed to adequately prevent potential cross-contamination of active pharmaceutical ingredients (APIs) due to inadequate controls, shared corridors, and insufficient cleaning validation. This indicates a serious concern regarding the integrity and safety of their manufactured APIs.
View Company Profile
ID · 2af59f72-4493-4231-8649-9a46b8a0f3ae
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.